Short-term activation induces multifunctional dendritic cells that generate potent antitumor T-cell responses in vivo. Apr 2009 - Cancer Immunol. Immunother.; 58(6):1432-0851 [PMID:18953536] [Wurzenberger C] [Koelzer VH] [Schreiber S] [Anz D] [Vollmar AM] [Schnurr M] [Endres S] [Bourquin C]
Dendritic cell-based vaccination combined with gemcitabine increases survival in a murine pancreatic carcinoma model. Aug 2007 - Gut; 56(9):0017-5749 [PMID:17395611] [Bauer C] [Bauernfeind F] [Sterzik A] [Orban M] [Schnurr M] [Lehr HA] [Endres S] [Eigler A] [Dauer M]
Chemosensitization of pancreatic carcinoma cells to enhance T cell-mediated cytotoxicity induced by tumor lysate-pulsed dendritic cells. Jul 2005 - J. Immunother.; 28(4):1524-9557 [PMID:16000951] [Dauer M] [Herten J] [Bauer C] [Renner F] [Schad K] [Schnurr M] [Endres S] [Eigler A]
Dendritische Zellen – Träger tumorgerichteter Immuntherapie Sep 2002 - Deutsches Ärzteblatt 99, Ausgabe 37 vom 13.09.2002, Seite A-2408 / B-2058 / C-1929 [Schnurr M] [Galambos P] [Scholz C] [Dauer M] [Krug A] [Hartmann G] [Eigler A] [Endres S]
Tumor cell lysate-pulsed human dendritic cells induce a T-cell response against pancreatic carcinoma cells: an in vitro model for the assessment of tumor vaccines. Aug 2001 - Cancer Res.; 61(17):0008-5472 [PMID:11522639] [Schnurr M] [Galambos P] [Scholz C] [Then F] [Dauer M] [Endres S] [Eigler A]
